The University of Michigan Wellness for Liver Health Study
1 other identifier
interventional
11
1 country
1
Brief Summary
The goal of this proposal is to pilot test our existing very-low carbohydrate diet intervention, adapted for adults with Non-alcoholic Fatty Liver Disease (NAFLD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2021
CompletedFirst Posted
Study publicly available on registry
August 18, 2021
CompletedStudy Start
First participant enrolled
August 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2022
CompletedResults Posted
Study results publicly available
August 14, 2023
CompletedAugust 14, 2023
August 1, 2023
1.1 years
August 10, 2021
June 6, 2023
August 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Liver Fat Content Using Liver MRI-derived Proton Density Fat Fraction
Measured with pre and post MRIs
4 months
Secondary Outcomes (2)
Change in Liver Stiffness
4 months
Body Weight Change
4 months
Study Arms (1)
diet and lifestyle program
EXPERIMENTALParticipants will be taught how to follow a very low carbohydrate, ketogenic diet, become more physically active, and get adequate sleep. They will also be taught about positive affect skills (such as gratitude, positive reappraisal, and personal strengths) and mindful eating.
Interventions
Eligibility Criteria
You may qualify if:
- have regular access to the internet
- MRI with liver steatosis but nor cirrhosis
- Able to consent and follow directions
- No physical limitations
- Physician approval to participate
- Able to attend in-person appointments in Ann Arbor
- Be identified based on information from the Michigan Genomics Initiative (MGI) database
- have elevated liver function tests
You may not qualify if:
- non-English speaking
- inability to complete baseline measurements
- a substance abuse, mental health, or medical condition that would interfere with participation (such as current chemotherapy, heart failure, kidney failure, Cushing's syndrome, etc.)
- pregnant or planning to get pregnant in the next 6 months
- type 1 diabetes
- non-NAFLD causes of elevated liver function tests
- planned or history of weight loss surgery
- vegan or vegetarian
- currently enrolled in a weight loss program or other investigative study that might conflict with this research
- taking medications known to cause weight gain or loss
- recent decompensation/hospitalization
- metal implants/inability to receive MRI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- National Institutes of Health (NIH)collaborator
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Laura Saslow, Associate Professor
- Organization
- University of Michigan
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 10, 2021
First Posted
August 18, 2021
Study Start
August 31, 2021
Primary Completion
October 3, 2022
Study Completion
October 3, 2022
Last Updated
August 14, 2023
Results First Posted
August 14, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share